New painkillers could thwart opioids’ fatal flaw

Previous PostJenrin Discovery's IND Application for Its Peripherally Restricted Cannabinoid-1 Receptor Inverse Agonist NASH Compound Was Cleared by the FDA to Begin Phase 1 Clinical Trials